Nicole Duclos

1.1k total citations
9 papers, 551 citations indexed

About

Nicole Duclos is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Nicole Duclos has authored 9 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Nicole Duclos's work include Chronic Myeloid Leukemia Treatments (6 papers), Eosinophilic Disorders and Syndromes (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Nicole Duclos is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Eosinophilic Disorders and Syndromes (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Nicole Duclos collaborates with scholars based in United States and Switzerland. Nicole Duclos's co-authors include Ifor R. Williams, Donna Neuberg, Doriano Fabbro, James D. Griffin, David P. Curley, Christina Boulton, D. Gary Gilliland, D. Gary Gilliland, Benjamin H. Lee and Brian J.P. Huntly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Nicole Duclos

9 papers receiving 533 citations

Peers

Countries citing papers authored by Nicole Duclos

Since Specialization

Citations

This map shows the geographic impact of Nicole Duclos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Duclos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Duclos more than expected).

Fields of papers citing papers by Nicole Duclos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Duclos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Duclos. The network helps show where Nicole Duclos may publish in the future.

Co-authorship network of co-authors of Nicole Duclos

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Duclos. A scholar is included among the top collaborators of Nicole Duclos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Duclos. Nicole Duclos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies 2005 ·Oncogene ·Jing Chen, Benjamin H. Lee, Ifor R. Williams, Jeffery L. Kutok, Constantine S. Mitsiades, Nicole Duclos, (unknown), Jennifer Adelsperger, Rachel Okabe, (unknown), Sandra Moore, Brian J.P. Huntly, Doriano Fabbro, Kenneth C. Anderson, James D. Griffin, (unknown)	72
2	FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model 2005 ·Oncogene ·Benjamin H. Lee, Ifor R. Williams, Ema Anastasiadou, Christina Boulton, (unknown), (unknown), David P. Curley, Nicole Duclos, Brian J.P. Huntly, Doriano Fabbro, James D. Griffin, (unknown)	60
3	Constitutively activated FGFR3 mutants signal through PLCγ-dependent and -independent pathways for hematopoietic transformation 2005 ·Blood ·Jing Chen, Ifor R. Williams, Benjamin H. Lee, Nicole Duclos, Brian J.P. Huntly, Daniel J. Donoghue, D. Gary Gilliland	35
4	Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin 2004 ·Journal of Clinical Investigation ·Jing Chen, Nathan R. Wall, (unknown), Nicole Duclos, Doriano Fabbro, Donna Neuberg, James D. Griffin, Yang Shi, D. Gary Gilliland	52
5	Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin 2004 ·Journal of Clinical Investigation ·Jing Chen, Nathan R. Wall, (unknown), Nicole Duclos, Doriano Fabbro, Donna Neuberg, James D. Griffin, Yang Shi, D. Gary Gilliland	43
6	PKC412 Effectively Inhibits Constitutively Activated FGFR3 Mutants in Murine Leukemia Models and t(4;14) Myeloma Cell Lines. 2004 ·Blood ·Jing Chen, Benjamin H. Lee, Ifor R. Williams, Jeffery L. Kutok, Nicole Duclos, (unknown), Jennifer Adelsperger, Rachel Okabe, (unknown), Sandra Moore, Brian J.P. Huntly, Constantine S. Mitsiades, Kenneth C. Anderson, James D. Griffin, Doriano Fabbro, D. Gary Gilliland	1
7	Positive and negative regulatory roles of the WW-like domain in TEL-PDGFβR transformation 2004 ·Blood ·Jing Chen, Ifor R. Williams, Jeffery L. Kutok, Nicole Duclos, Ema Anastasiadou, Shane C. Masters, Haian Fu, D. Gary Gilliland	12
8	CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML) 2002 ·Cancer Cell ·Louise Kelly, Jin‐Chen Yu, Christina Boulton, Mutiah Apatira, Jason Li, Carol M. Sullivan, Ifor R. Williams, (unknown), David P. Curley, Nicole Duclos, Donna Neuberg, Robert M. Scarborough, Anjali Pandey, Stanley J. Hollenbach, Keith Abe, Nathalie A. Lokker, D. Gary Gilliland, Neill A. Giese	240
9	Neuroinvasion by a Creutzfeldt–Jakob disease agent in the absence of B cells and follicular dendritic cells 2001 ·Proceedings of the National Academy of Sciences ·Mark J. Shlomchik, (unknown), Nicole Duclos, Laura Manuelidis	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact